Delivery Order SPE2DB24D2003-SPE2DB25FXGU1

Award Date 4/14/25
Potential Completion Date 4/15/25
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,199.06 contract is for the supply of 4,567,790,837 units of the drug ZENPEP (40,000 units per capsule, 100 capsules per bottle). The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a $1,275.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,296,656 units of ZENPEP DR 10,000 UNIT CAPSULE 100S, a pharmaceutical product. The award has an ultimate completion date of July 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,383.30 firm fixed-price contract is for the delivery of 60,000 units of the pharmaceutical drug ZENPEP DR 100S, with a period of performance through February 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 20,000 unit capsules of the drug ZENPEP DR 100S. The $2,972.08 firm fixed-price contract has a completion date of February 20, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is a delivery order valued at $11,787.39 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S, a medical product, with a period of performance through February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) is a Firm Fixed Price Delivery Order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,697.70 contract is for the supply of 40,000-unit capsules of the drug ZENPEP DR, with an ultimate completion date of November 21, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,332.66, is for the delivery of ZENPEP DR 60,000 UNIT CAPSULE 100S, a pharmaceutical drug product. The contract has a period of performance through December 31, 2024 and is a firm fixed-price arrangement. No set-aside requirements were used for this award. Amerisourcebergen Drug Corp is...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $15,434.99 firm-fixed-price contract is for the supply of 40,000 units of the prescription drug Zenpep in 100-count capsule bottles. The award does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation. The order, valued at $8,319.47, is for the delivery of 40,000 unit capsules of the prescription drug ZENPEP. This award does not have a set-aside designation. The delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract with DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,127.68 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 4,564,242,620 ZENPEP DR 15,000 UNIT CAPSULES 100S, a pharmaceutical product, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB25FXGU1
    Delivery Order

This is a $9,017.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,908,548 units of the drug ZENPEP DR 40,000 UNIT CAPSULE 100S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order does not have a set-aside designation, indicating open competition.

Generated 7/14/25, 10:48 AM